153 related articles for article (PubMed ID: 38733530)
1. circPDK1 competitively binds miR-4731-5p to mediate GIGYF1 expression and increase paclitaxel sensitivity in non-small cell lung cancer.
Feng Y; Zhang T; Liu H
Discov Oncol; 2024 May; 15(1):157. PubMed ID: 38733530
[TBL] [Abstract][Full Text] [Related]
2. Hsa_circ_0092887 targeting miR-490-5p/UBE2T promotes paclitaxel resistance in non-small cell lung cancer.
Wang L; Zhang Z; Tian H
J Clin Lab Anal; 2023 Jan; 37(1):e24781. PubMed ID: 36550019
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA circ_0000376 promotes paclitaxel resistance and tumorigenesis of non-small cell lung cancer via positively modulating KPNA4 by sponging miR-1298-5p.
Hu S; Zhang Q; Sun J; Xue J; Wang C
Thorac Cancer; 2023 Aug; 14(22):2116-2126. PubMed ID: 37455373
[TBL] [Abstract][Full Text] [Related]
4. Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis.
Guo C; Wang H; Jiang H; Qiao L; Wang X
Cancer Biother Radiopharm; 2022 Mar; 37(2):84-95. PubMed ID: 32833503
[No Abstract] [Full Text] [Related]
5. Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p.
Li J; Fan R; Xiao H
Cancer Cell Int; 2021 Jan; 21(1):15. PubMed ID: 33407505
[TBL] [Abstract][Full Text] [Related]
6. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
7. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression.
Li Y; Ma Z; Luo M; Liang R
Anticancer Drugs; 2022 Nov; 33(10):1024-1034. PubMed ID: 36206095
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0057104, by competitive adsorption of miR-627-5p, mediates CCND2 expression to promote malignant proliferation and Warburg effect of colorectal cancer.
Zhang L; Xu J; Jiang D; Zhang J; Li H; Zhao Z; Mei Z
Biotechnol Genet Eng Rev; 2023 May; ():1-17. PubMed ID: 37130193
[TBL] [Abstract][Full Text] [Related]
9. Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR-136-5p/YWHAZ axis.
Kong Z; Han Q; Zhu B; Wan L; Feng E
Thorac Cancer; 2023 Jul; 14(19):1831-1842. PubMed ID: 37192740
[TBL] [Abstract][Full Text] [Related]
10. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
[TBL] [Abstract][Full Text] [Related]
11. Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway.
Li J; Zhang Z; Hu Y; Wei Q; Shao X
Anticancer Drugs; 2022 Oct; 33(9):883-892. PubMed ID: 36136988
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of circNRIP1 Suppresses the Paclitaxel Resistance of Ovarian Cancer via Regulating the miR-211-5p/HOXC8 Axis.
Li M; Cai J; Han X; Ren Y
Cancer Manag Res; 2020; 12():9159-9171. PubMed ID: 33061608
[TBL] [Abstract][Full Text] [Related]
13. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis.
Liu Y; Li C; Liu H; Wang J
Pharmacol Res Perspect; 2021 Aug; 9(4):e00812. PubMed ID: 34219377
[TBL] [Abstract][Full Text] [Related]
14. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
Tao L; Wu YQ; Zhang SP
Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
[TBL] [Abstract][Full Text] [Related]
15. Circ_0020123 promotes non-small cell lung cancer progression via miR-146a-5p mediated regulation of EIF4G2 expression.
Wei Z; Liu J; Hui G; Luan X
Thorac Cancer; 2024 Jan; 15(1):44-56. PubMed ID: 37993106
[TBL] [Abstract][Full Text] [Related]
16. LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2.
Huang N; Guo W; Ren K; Li W; Jiang Y; Sun J; Dai W; Zhao W
Front Oncol; 2019; 9():1103. PubMed ID: 31696057
[TBL] [Abstract][Full Text] [Related]
17. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
Zhang W; Song C; Ren X
Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
[TBL] [Abstract][Full Text] [Related]
18. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.
Sun H; Zhou X; Bao Y; Xiong G; Cui Y; Zhou H
Open Biol; 2019 Jul; 9(7):180227. PubMed ID: 31337279
[TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_0003489 Drives PTX Resistance of Human NSCLC Cells Through Modulating miR-98-5p/IGF2.
Xia S; Wang C
Pharmgenomics Pers Med; 2023; 16():805-815. PubMed ID: 37692338
[TBL] [Abstract][Full Text] [Related]
20. Effects of miR-145-5p on cardiomyocyte proliferation and apoptosis, GIGYF1 expression and oxidative stress response in rats with myocardial ischemia-reperfusion.
Liang C; Wang S; Zhao L; Han Y; Zhang M
Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):147-159. PubMed ID: 35809317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
